CrushSCI.com
177.2Average days
162Median days
110Fastest days
347Longest days
4672025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

172 days

LYPLA2 inhibition alleviates hepatic sinusoidal obstruction syndrome by suppressing pSTAT3-dependent HSP60 transcription

Authors
Xiaofei Ren; Haiwang Zhang; Rutao Hong; Xinyan DuShow moreShow less
Affiliations
Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, China; First Clinical Medical College (First Affiliated Hospital), Anhui Medical University, Hefei, ChinaShow moreShow less
Source PDF DOI Publisher page
123 days

Single-cell and multi-algorithm profiling identifies SNRPG as a Claudin-1-associated regulator of malignant progression in triple-negative breast cancer

Authors
Zhihao Ye; Jiancheng Mou; Haotian Su; Jie Luo; Yingyue Cheng; Ke Liu; Zhuotao Yang; Da Qian; Hongchao Tang; Mingxing Xu; Yuxiao Mu; Yuning Tang; Wenjuan Gui; Youpeng Pan; Yi Chen; Xuli Meng; Qinghui ZhengShow moreShow less
Affiliations
General Surgery, Cancer Center, Department of Breast Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China; Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Provincial People's Hospital), Hangzhou, Zhejiang, 310000, China; The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, People's Republic of China; The Second School of Clinical Medicine, Hangzhou Normal University, Hangzhou, Zhejiang, 310053, People's Republic of China; Department of Burn and Plastic Surgery-Hand Surgery, Changshu Hospital Affiliated to Soochow University, Changshu No. 1 People's Hospital, Changshu, 215500, China; Transvascular Implant Instrument Research Institute, The Second Affiliated Hospital, Zhejiang University School of Medicine, Binjiang District, Hangzhou, 310053, ChinaShow moreShow less
Source PDF DOI Publisher page
258 days

Multi-omics analysis reveals osteocyte loss as a potential trigger for liver lipid metabolic disorder

Authors
Yuchen Tian; Siyuan Zhu; Chenyi Jiang; Fang Ye; Senyao Zhang; Bingqi Wang; Yiyang Ma; Yidan Pang; Changqing Zhang; Junjie Gao; Peng Liao; Peng Ding; Zhiwei LiShow moreShow less
Affiliations
Department of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China; Institute of Microsurgery on Extremities, Department of Orthopedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China; Department of General Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, Zhejiang, 311121, China; Department of Medicine, The University of Hong Kong, Hong Kong; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaShow moreShow less
Source PDF DOI Publisher page
148 days

LGR4 interacts with RhoA to modulate cell survival and epithelial-mesenchymal transition via the Wnt/β-catenin pathway in benign prostatic hyperplasia

Authors
Jizhang Qiu; Huan Liu; Xiaolong Ma; Lu Du; Jiang Liu; Yongying Zhou; Yiqiao Zhao; Yuhan Zhu; Hejin Wang; Yongwen Luo; Xinhua ZhangShow moreShow less
Affiliations
Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan , 430071, China; Department of Urology , the Affiliated LiHuiLi Hospital of Ningbo University, Ningbo University, Ningbo, China; Department of Urology, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute , Shenyang, ChinaShow moreShow less
Source PDF DOI Publisher page
116 days

USF1 promotes growth and glycolysis in acute myeloid leukemia cells

Authors
Nianxue Wang; Yunshuang Guan; Ruya Zhang; Can Yang; Liping Shu; Xijun WuShow moreShow less
Affiliations
Department of Immunology, Basic Medical School, Guizhou Medical University, Guiyang, Guizhou, 561113, China; Department of Pediatric Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, 550004, China; Clinical Lab, The Second People's Hospital of Guiyang, Guiyang, Guizhou, 550004, ChinaShow moreShow less
Source PDF DOI Publisher page
347 days

Loss of PIMREG impairs double-strand break signaling and repair

Authors
Maria Vitória de Rizzo Gasparini; Laís do Carmo; Giovanna Gonçalves de Almeida; Mariana Siqueira Lacerda Mamede; Isabela David Cardoso; Lígia Arantes Sardinha; Isabela Spido Dias; Jennifer Ann Black; Vanessa Cristina Arfelli; Yun-Chien Chang; Elza Tiemi Sakamoto Hojo; Stephanie Heinzlmeir; Bernhard Kuster; Philipp A. Greif; Leticia Fröhlich ArchangeloShow moreShow less
Affiliations
Department of Cellular and Molecular Biology and Pathogenic Bioagents, Ribeirão Preto Medical School, University of São Paulo (FMRP-USP), Ribeirão Preto, São Paulo, Brazil; University of Glasgow Centre for Parasitology, School of Infection and Immunity, Sir Graeme Davies Building, 120 University Place, Glasgow, G12 8TA, United Kingdom; Laboratory for Experimental Leukemia and Lymphoma Research, Munich University Hospital, Ludwig-Maximilians University (LMU), Munich, Germany; Chair of Proteomics and Bioanalytics, School of Life Sciences Weihenstephan, Technical University of Munich (TUM), Freising, Germany; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (FMRP-USP), Ribeirão Preto, São Paulo, Brazil; Department of Biology, Faculty of Philosophy Sciences and Letters at Ribeirão Preto, University of São Paulo (FFCLRP-USP), Ribeirão Preto, São Paulo, Brazil; German Cancer Consortium (DKTK), partner site Munich, Germany; German Cancer Research Center (DKFZ), Heidelberg, GermanyShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE take to review a manuscript?

As of 2026-11-19, CrushSCI has 16 complete review records for BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. The fastest paper went from submission to acceptance in 110 days (Hepatic methionine-cycle dysregulation is associated with immune-inflammatory and fibrogenic remodeling in biliary atresia, received 2026-04-23, accepted 2026-08-11); the slowest took 347 days. The average is 177.2 days and the median is 162 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.